Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07442396

The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation

The aim is to investigate the effectiveness of exercise in the treatment of erectile dysfunction and premature ejaculation.

Recruiting

Interested in participating?

Request Info

Key information

Age range

25 year–45 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Uskudar university

Istanbul, Turkey (Türkiye)

Location status: Recruiting

Location contact

Ömer Şevgi

CONTACT

[email protected]

About this study

The study was designed as a randomized controlled trial. Participants were divided into two equal groups: a control group and an exercise group. Patients in the control group were followed with normal conventional medical treatment, while participants in the exercise group underwent an 8-week, 3-day-a-week exercise program. All participants were evaluated before and after treatment using the Index of Erectile Function, the World Health Organization Quality of Life Short Form, and the Premature Ejaculation Diagnostic Tool.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male individuals aged 25-45 years
  • Individuals diagnosed with erectile dysfunction and premature ejaculation
  • Individuals who voluntarily agree to participate in the study and sign the informed consent form
  • Individuals who have the physical and cognitive capacity to participate in pelvic floor physiotherapy applications

Exclusion criteria

  • Individuals with a history of surgery in the pelvic region
  • Individuals with a diagnosis of neurological disease or neurological disorder that may affect pelvic floor muscle function
  • Presence of active infection, inflammation, or painful pathology in the pelvic region
  • Individuals who regularly use medications that significantly affect sexual function
  • Individuals with serious psychiatric illness or cognitive impairment that may hinder study compliance

Treatment and study plan

Control

Other

Patients in the control group will be followed with normal conventional medical treatment.

Other names: medical treatment

Exercise

Other

Participants in the exercise group will undergo an 8-week, 3-day-a-week exercise program.

Other names: Pelvic Floor Exercise Group

Primary outcomes

  1. International Index of Erectile Dysfunction

    Time frame: 10 weeks

    Mean change in International Index of Erectile Dysfunction scores. There are five specific areas addressed including Erectile Function (questions:1-5 & 15;score range: 0-5, maximum score:30); Orgasmic Function (questions:9-10; score range:0-5; maximum score:10); Sexual desire (questions:11-12; score range:1-5; maximum score:10); Intercourse satisfaction (questions:6-8; score range:0-5; maximum score:15); Overall satisfaction (questions:13-14; score range:1-5; maximum score:10). The lower the score represents greater dysfunction within each domain.

  2. Premature Ejaculation Diagnostic Tool

    Time frame: 10 weeks

    it was developed by Symonds et al. (2007) to better define premature ejaculation for use in clinical studies, this is a 5-point Likert-type scale consisting of 5 items. The scale was adapted to Turkish by Serefoglu et al. (2009). The highest score that can be obtained from the scale is 20.0 and the lowest score is 0.0. Scores higher than 11 are defined as "Premature Ejaculation", scores of 9-10 are defined as "possible Premature Ejaculation", and scores of eight or less are defined as "no Premature Ejaculation".

Study contacts

Contact information is provided by the study sponsor or research team.

Ömer ŞEVGİN

CONTACT

[email protected]

+905069787535

Sponsors and collaborators

Lead sponsor

Uskudar University

Other

Registry information

Official study title

The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation: a Randomized Controlled Trial.

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Mar 2, 2026
Registry last updated
Mar 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.